"Patients with stage III or IV kidney cancer are at high risk of recurrence ... which has many more mutations and therefore ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...
The advent of vaccinations came when a scientist, by the name of Edward Jenner, discovered that an individual exposed to a ...
A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...
"Patients with stage III or IV kidney cancer are at high risk ... and therefore many possible neoantigens. But kidney cancer is a disease with fewer mutations, and therefore fewer targets to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results